Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Recurrence
研究概览
简要总结
This observational study aims to establish a prospective nationwide cohort of venous thromboembolism. The main questions it mains to answer are:
- Which patients with venous thromboembolism should accept long-term anticoagulation therapy?
- Mechanism and prognosis of venous thromboembolism. Participants will receive yearly follow-ups through telephone, hospitalization, or outpatient care.
详细描述
Venous thromboembolism (VTE), including deep venous thrombosis and pulmonary embolism, is a class of diseases with strong occultation, high mortality, and a high recurrence rate.Long-term anticoagulant therapy can reduce the risk of recurrence. Although long-term anticoagulation can reduce the risk of VTE recurrence, it will also increase the risk of major bleeding and the economic burden of long-term anticoagulation. Therefore, stratifying the risk of VTE recurrence and preventing recurrence with accurate anticoagulant therapy is an urgent problem in VTE management.
Investigators will establish a prospective nationwide cohort of VTE, develop a unified follow-up plan, and conduct whole-life follow-up management for patients. Demographic, clinical, imaging, laboratory indicators, gene, and other information of patients will be collected. A VTE patient database with complete clinical phenotype data, genetic data, and biological samples will be established.
Investigators will construct a VTE recurrence risk prediction model based on Chinese data to provide clinical decision suggestions for clinicians to select appropriate individualized anticoagulant duration according to risk stratification. VTE patients with low recurrence risk could avoid long-term anticoagulant therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age greater or equal to
- •Patients diagnosed with venous thromboembolism.
排除标准
- •Pregnant or lactating women
- •Patients with active tumor
结局指标
主要结局
Recurrence
时间窗: through study completion, an average of 1 year
recurrence of venous thromboembolism
次要结局
- Bleeding episode(through study completion, an average of 1 year)
- All-cause death(through study completion, an average of 1 year)
研究者
Lu Hua
Chief Physician
China National Center for Cardiovascular Diseases
